Nos publications

1- Effect of temporary suspension of chronic immunosuppressive drugs on day-90 mortality and ICU-acquired infections among critically ill patients with solid organ transplant: a retrospective multicenter study. Vaidie J, Demiselle J, Gabriel A, Guillon A, Peju E, Pène F, et al. Intensive Care Med. 2025 Aug;51(8):1442-1452. doi: 10.1007/s00134-025-08024-7. Epub 2025 Jul 16. PMID: 40668232

2- Left ventricular diastolic dysfunction is prevalent but not associated with mortality in patients with septic shock. Vignon P, Charron C, Legras A, Musset F, Slama M, Prat G, et al. Intensive Care Med. 2025 Jan;51(1):94-105. doi: 10.1007/s00134-024-07748-2. Epub 2025 Jan 7. PMID: 39774865

3- Management of hematological patients requiring emergency chemotherapy in the intensive care unit. Lafarge A, Chean D, Whiting L, Clere-Jehl R; Groupe de Recherche en Réanimation Respiratoire du patient d’Onco-Hématologie (GRRR-OH); Clinical Research in Intensive Care and Sepsis - TRIal Group for Global Evaluation and Research in SEPsis (CRICS-TRIGGERSEP). Intensive Care Med. 2024 Jun;50(6):849-860. doi: 10.1007/s00134-024-07454-z. Epub 2024 May 15. PMID: 38748265. Review.

4- Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial. Heming N, Renault A, Kuperminc E, Brun-Buisson C, Megarbane B, et al. Lancet Respir Med. 2024 May;12(5):366-374. doi: 10.1016/S2213-2600(23)00430-7. Epub 2024 Feb 1. PMID: 38310918

5- Inhaled amikacin to prevent ventilator-associated pneumonia. Ehrmann S, Barbier F, Demiselle J, Quenot JP, Herbrecht JE, Roux D, et al. N Engl J Med. 2023 Nov 30;389(22):2052-2062. doi: 10.1056/NEJMoa2310307. Epub 2023 Oct 25. PMID: 37888914

6- Correction: Influence of socio-economic status on functional recovery after ARDS caused by SARS-CoV-2: the multicentre, observational RECOVIDS study. Declercq PL, Fournel I, Demeyere M, Berraies A, Ksiazek E, Nyunga M, et al. Intensive Care Med. 2023 Nov;49(11):1438-1439. doi: 10.1007/s00134-023-07217-2. PMID: 37755457

7- Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial. François B, Lambden S, Fivez T, Gibot S, Derive M, Grouin JM, et al. Lancet Respir Med. 2023 Oct;11(10):894-904. doi: 10.1016/S2213-2600(23)00158-3. Epub 2023 May 31. PMID: 37269870

8- Low versus standard calorie and protein feeding in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3). Reignier J, Plantefeve G, Mira JP, Argaud L, Asfar P, Aissaoui N, et al. Lancet Respir Med. 2023 Jul;11(7):602-612. doi: 10.1016/S2213-2600(23)00092-9. Epub 2023 Mar 20. PMID: 36958363

9- Hydrocortisone in severe community-acquired pneumonia. Dequin PF, Meziani F, Quenot JP, Kamel T, Ricard JD, Badie J, et al. N Engl J Med. 2023 May 25;388(21):1931-1941. doi: 10.1056/NEJMoa2215145. Epub 2023 Mar 21. PMID: 36942789

10- Effect of high-flow nasal cannula oxygen vs standard oxygen therapy on mortality in patients with respiratory failure due to COVID-19: the SOHO-COVID randomized clinical trial. Frat JP, Quenot JP, Badie J, Coudroy R, Guitton C, Ehrmann S, et al. JAMA. 2022 Sep 27;328(12):1212-1222. doi: 10.1001/jama.2022.15613. PMID: 36166027

11- High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial. Coudroy R, Frat JP, Ehrmann S, Pène F, Decavèle M, Terzi N, et al. Lancet Respir Med. 2022 Jul;10(7):641-649. doi: 10.1016/S2213-2600(22)00096-0. Epub 2022 Mar 21. PMID: 35325620

12- Factors associated with acute mesenteric ischemia among critically ill ventilated patients with shock: a post hoc analysis of the NUTRIREA2 trial. Piton G, Le Gouge A, Boisramé-Helms J, Anguel N, Argaud L, Asfar P, et al. Intensive Care Med. 2022 Apr;48(4):458-466. doi: 10.1007/s00134-022-06637-w. Epub 2022 Feb 22. PMID: 35190840

13- Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label metatrial. Ehrmann S, Li J, Ibarra-Estrada M, Perez Y, Pavlov I, McNicholas B, et al. Lancet Respir Med. 2021 Dec;9(12):1387-1395. doi: 10.1016/S2213-2600(21)00356-8. Epub 2021 Aug 20. PMID: 34425070